Pharmacology and Therapeutic Potential of the 5-HT7 Receptor

被引：35

作者：

Blattner, Kevin M. ^{[1
]}

Canney, Daniel J. ^{[1
]}

Pippin, Douglas A. ^{[2
]}

Blass, Benjamin E. ^{[1
]}

机构：

[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Moulder Ctr Drug Discovery Res, 3307 North Broad St, Philadelphia, PA 19140 USA

[2] Praeventix LLC, 665 Stockton Dr,Suite 200H, Exton, PA 19341 USA

来源：

ACS CHEMICAL NEUROSCIENCE | 2019年 / 10卷 / 01期

关键词：

Serotonin receptor; serotonin (5-HT); G-protein-coupled receptor (GPCR); 5-HT7; receptor; agonist; antagonist; PROTEIN-KINASE-A; EXTRACELLULAR-REGULATED KINASE; ANTEROVENTRAL PREOPTIC REGION; ANTIDEPRESSANT-LIKE BEHAVIOR; MULTIOBJECTIVE BASED DESIGN; PHRENIC MOTOR FACILITATION; DEPRESSIVE-LIKE BEHAVIORS; GENOME-WIDE ASSOCIATION; BETA-CASEIN EXPRESSION; EYE-MOVEMENT SLEEP;

D O I：

10.1021/acschemneuro.8b00283

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

It is well-documented that serotonin (5-HT) exerts its pharmacological effects through a series of 5-HT receptors. The most recently identified member of this family, 5-HT7, was first identified in 1993. Over the course of the last 25 years, this receptor has been the subject of intense investigation, and it has been demonstrated that 5-HT7 plays an important role in a wide range of pharmacological processes. As a result of these findings, modulation of 5-HT7 activity has been the focus of numerous drug discovery and development programs. This review provides an overview of the roles of 5-HT7 in normal physiology and the therapeutic potential of this interesting drug target.

引用

页码：89 / 119

页数：61

共 50 条

[41] Characterization of the 5-HT7 receptor.: Determination of the pharmacophore for 5-HT7 receptor agonism and CoMFA-based modeling of the agonist binding site
Vermeulen, ES
Schmidt, AW
Sprouse, JS
Wikström, HV
Grol, CJ
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (25) : 5365 - 5374
[42] 5-HT1A/5-HT7 receptor interplay: Chronic activation of 5-HT7 receptors decreases the functional activity of 5-HT1A receptor and its сontent in the mouse brain
E. M. Kondaurova
D. V. Bazovkina
V. S. Naumenko
Molecular Biology, 2017, 51 : 136 - 142
[43] 5-HT1A/5-HT7 Receptor Interplay: Chronic Activation of 5-HT7 Receptors Decreases the Functional Activity of 5-HT1A Receptor and Its Content in the Mouse Brain
Kondaurova, E. M.
Bazovkina, D. V.
Naumenko, V. S.
MOLECULAR BIOLOGY, 2017, 51 (01) : 136 - 142
[44] Human 5-HT4 and 5-HT7 receptor splice vairants: Are they important?
Coupar, Ian M.
Desmond, Paul V.
Irving, Helen R.
CURRENT NEUROPHARMACOLOGY, 2007, 5 (04) : 224 - 231
[45] 5-HT4, 5-HT6, 5-HT7; Molecular pharmacology of adenylate cyclase stimulating receptors
Branchek, TA
SEMINARS IN THE NEUROSCIENCES, 1995, 7 (06): : 375 - 382
[46] Novel 3-aminochromans as potential pharmacological tools for the serotonin 5-HT7 receptor
Holmberg, P
Tedenborg, L
Rosqvist, S
Johansson, AM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 747 - 750
[47] Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands
Ofori, Edward
Zhu, Xue Y.
Etukala, Jagan R.
Peprah, Kwakye
Jordan, Kamanski R.
Adkins, Adia A.
Bricker, Barbara A.
Kang, Hye J.
Huang, Xi-Ping
Roth, Bryan L.
Ablordeppey, Seth Y.
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3464 - 3471
[48] Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands
Singh, Deepika
Singh, Priya
Srivastava, Pooja
Kakkar, Dipti
Pathak, Mallika
Tiwari, Anjani Kumar
BIOORGANIC CHEMISTRY, 2023, 131
[49] Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs
Bruheim, S
Krobert, KA
Andressen, KW
Levy, FO
RECEPTORS & CHANNELS, 2003, 9 (02): : 107 - 116
[50] IMPAIRED EFFECT OF ACTIVATION OF RAT HIPPOCAMPAL 5-HT7 RECEPTORS, INDUCED BY TREATMENT WITH THE 5-HT7 RECEPTOR ANTAGONIST SB 269970
Kusek, M.
Sowa, J.
Tokarski, K.
Hess, G.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2015, 66 (02): : 301 - 308

← 1 2 3 4 5 →